Payne Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$286K Buy
1,127
+83
+8% +$19.3K 0.08% 73
2026
Q1
$255K Sell
1,044
-18
-2% -$4.19K 0.08% 65
2025
Q4
$220K Sell
1,062
-26
-2% -$5.14K 0.07% 77
2025
Q3
$202K Sell
1,088
-336
-24% -$57.6K 0.06% 77
2025
Q2
$218K Buy
1,424
+132
+10% +$20.3K 0.08% 71
2025
Q1
$214K Buy
+1,292
New +$202K 0.09% 69

Other funds holding JNJ

Payne Capital Management's JNJ Position: Q2 2026 in Review

Payne Capital Management increased its Johnson & Johnson (JNJ) stake by 8% in Q2 2026, buying an estimated $19.3K and bringing the position to 1,127 shares worth $286K. The position accounts for 0.08% of the portfolio, ranked #73.

Payne Capital Management first reported a position in JNJ in Q1 2025 and has held it in 6 quarters since. 4,649 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Payne Capital Management held 1,127 shares of Johnson & Johnson worth $286K as of Q2 2026.
  • Payne Capital Management bought 83 Johnson & Johnson shares in Q2 2026, an estimated $19.3K.
  • Johnson & Johnson made up 0.08% of Payne Capital Management's portfolio in Q2 2026, its #73 holding.
  • Payne Capital Management first reported a position in Johnson & Johnson in Q1 2025 and has held it in 6 quarters since.
  • 4,649 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Payne Capital Management's 13F filing for Q2 2026, filed 17 Aug 2026.